Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.

Volz, T; Caroli, U; Lüdtke, H; Bräutigam, M; Kohler-Späth, H; Röcken, M; Biedermann, T

Volz, T; Caroli, U; Lüdtke, H; Bräutigam, M; Kohler-Späth, H; Röcken, M; Biedermann, T.

Affiliation

Volz T; Department of Dermatology, Eberhard Karls University, Liebermeisterstrasse 25, 72076 Tübingen, Germany.

Br J Dermatol ; 159(4): 936-41, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18647310

Subject(s)

Dermatologic Agents/administration & dosage; Lichen Planus, Oral/drug therapy; Tacrolimus/analogs & derivatives; Administration, Topical; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Tacrolimus/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus / Lichen Planus, Oral / Dermatologic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2008 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google